News Picture: A Bone Drug That Treats Baldness?

Alibris: Books, Music, & Movies
Anniversary Sale! Up to 25% OFF
50% Off Select Filtration Systems

Latest Skin News

TUESDAY, May 8, 2018 (HealthDay News) — A drug intended as a treatment for osteoporosis may help treat hair loss, researchers say.

“The fact this new agent, which had never even been considered in a hair loss context, promotes human hair growth is exciting because of its translational potential: It could one day make a real difference to people who suffer from hair loss,” said study leader Nathan Hawkshaw, of the University of Manchester in England.

Buy 2, Get 1 Free on Select Redken & Biolage Haircare at Beauty Brands. Shop Now.
Avéne USA
Bcbg Max Azria Group, LLC
728x90 banner

“Clearly though, a clinical trial is required next to tell us whether this drug or similar compounds are both effective and safe in hair loss patients,” Hawkshaw said in a university news release.

Only two drugsminoxidil (Rogaine) and finasteride (Propecia, Proscar) — exist to treat so-called male-pattern balding. Both have side effects and often produce disappointing hair regrowth results, the researchers noted.

Exploring other possible options, Hawkshaw and his colleagues discovered that the drug WAY-316606 reduces expression of a protein called SFRP1. This protein inhibits the development and growth of many tissues, including hair follicles.

When the researchers treated hair follicles with the drug, it enhanced their growth.

Free Shipping & 7% Off at BudgetPetCare Labor's Day Sale. Use Coupon: BPCLDS7
Blink Health
Mother’s Day Special: Take 12% Extra OFF Everything + Free Shipping Worldwide. Use Coupon: MDSALE12
Free US Shipping

WAY-316606 was originally developed to treat bone loss related to osteoporosis.

The researchers said clinical trials are needed to test the safety and effectiveness of this drug and similar compounds.

The study was published May 8 in the journal PLOS Biology.

— Robert Preidt

Copyright © 2018 HealthDay. All rights reserved.


SOURCE: University of Manchester, news release, May 8, 2018